Epigallocatechin gallate regulates the myeloid-specific transcription factor PU.1 in macrophages

PLoS One. 2024 Apr 25;19(4):e0301904. doi: 10.1371/journal.pone.0301904. eCollection 2024.

Abstract

Our previous research demonstrated that PU.1 regulates expression of the genes involved in inflammation in macrophages. Selective knockdown of PU.1 in macrophages ameliorated LPS-induced acute lung injury (ALI) in bone marrow chimera mice. Inhibitors that block the transcriptional activity of PU.1 in macrophages have the potential to mitigate the pathophysiology of LPS-induced ALI. However, complete inactivation of PU.1 gene disrupts normal myelopoiesis. Although the green tea polyphenol Epigallocatechin gallate (EGCG) has been shown to regulate inflammatory genes in various cell types, it is not known if EGCG alters the transcriptional activity of PU.1 protein. Using Schrodinger Glide docking, we have identified that EGCG binds with PU.1 protein, altering its DNA-binding and self-dimerization activity. In silico analysis shows that EGCG forms Hydrogen bonds with Glutamic Acid 209, Leucine 250 in DNA binding and Lysine 196, Tryptophan 193, and Leucine 182 in the self-dimerization domain of the PU.1 protein. Experimental validation using mouse bone marrow-derived macrophages (BMDM) confirmed that EGCG inhibits both DNA binding by PU.1 and self-dimerization. Importantly, EGCG had no impact on expression of the total PU.1 protein levels but significantly reduced expression of various inflammatory genes and generation of ROS. In summary, we report that EGCG acts as an inhibitor of the PU.1 transcription factor in macrophages.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Catechin* / analogs & derivatives*
  • Catechin* / pharmacology
  • DNA / metabolism
  • Gene Expression Regulation / drug effects
  • Lipopolysaccharides / pharmacology
  • Macrophages* / drug effects
  • Macrophages* / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Molecular Docking Simulation
  • Protein Binding
  • Proto-Oncogene Proteins* / genetics
  • Proto-Oncogene Proteins* / metabolism
  • Trans-Activators* / genetics
  • Trans-Activators* / metabolism

Substances

  • Catechin
  • epigallocatechin gallate
  • proto-oncogene protein Spi-1
  • Trans-Activators
  • Proto-Oncogene Proteins
  • DNA
  • Lipopolysaccharides

Grants and funding

MK 17SDG33410982 American Heart Association (heart.org) JWC HL137224 National Institutes of Health (nih.gov). Dehua Pei GM122459 - support for EGCG labeling, HPLC, Spectrometer studies, National Institutes of Health (nih.gov). Confocal Images presented in this report were generated using the instruments and services at the Campus Microscopy and Imaging Facility, The Ohio State University, supported in part by grant P30 CA016058, National Cancer Institute, Bethesda, MD. OSU flow cytometry analysis is supported by P30CA016058. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.